Roshni Dasgupta, MD, MPH, is a pediatric surgeon. She is a professor with the University Of Cincinnati College Of Medicine. Dr. Dasgupta obtained her medical degree at the University of Toronto. She finished her residency at Massachusetts General Hospital at Harvard Medical School. She completed a Rhodes scholarship at the University of Oxford in Oxford England, followed by a Pediatric Surgery Fellowship at the Hospital for Sick Children in Toronto, Canada. She also completed her Master of Public Health at the Harvard School of Public Health. Her clinical interests are in surgical oncology and vascular anomalies.
Dr. Dasgupta is the current chair of the American Pediatric Surgical Association (APSA) Cancer Committee, Pediatric Surgical Oncology Research Collaborative, as well as the chair on the American Academy for Pediatrics (AAP). Delivery of Surgical Care Committee. She has a significant interest in Quality Improvement and is the American College of Surgery National Surgery Quality Improvement Program (NSQIP) Surgical Champion. She is the surgical director of the Vascular Anomalies Clinic, as well as surgical director of Quality Improvement for Pediatric Surgery.
MD: University of Toronto, Toronto Canada, 1996.
Residency: Massachusetts General Hospital, Harvard Medical School 1996-2003.
Research Fellowship: University of Oxford, Oxford, England.
Fellowship: Hospital for Sick Children, Toronto, Canada.
MPH: Harvard School of Public Health, Boston, MA, 2009.
Surgical oncology; vascular malformations; minimally invasive surgery; general pediatric surgery
Colorectal Disorders, Surgery - General and Thoracic, Rare Lung Diseases, Hemangioma and Vascular Malformations
Oncology and vascular malformations
General and Thoracic Surgery
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate-risk rhabdomyosarcoma: A report from Children's Oncology Group. Pediatric Blood and Cancer. 2023; 70:e30436.
Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas. Pediatric Blood and Cancer. 2023; 70 Suppl 6:e30556.
Multi-institutional assessment of the prevalence of neuroendocrine tumors in children undergoing laparoscopic appendectomy for acute appendicitis in the United States. Pediatric Blood and Cancer. 2023; e30620.
Transition of Care from Pediatric to Adult Surgery. Pediatric Collections: Adolescent Health Care Part 3: Transition of Care. : American Academy of Pediatrics (AAP); American Academy of Pediatrics (AAP); 2023.
Disparities in care of pediatric, adolescent, and young adult patients with solid tumors: A systematic review. Pediatric Blood and Cancer. 2023; 70:e30355.
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatric Blood and Cancer. 2023; 70:e30357.
Management and Outcomes of Wilms Tumor with Suprarenal Intravascular Extension: A Pediatric Surgical Oncology Research Collaborative Study. Annals of Surgery. 2023; Publish Ahead of Print.
Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases. Journal of Clinical Oncology. 2023; 41:11535.
ASO Author Reflections: Minimizing Time in Hospital via Bone Biopsy or Other Means. Annals of Surgical Oncology. 2023; 30:3666.
ASO Visual Abstract: Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?. Annals of Surgical Oncology. 2023; 30:3667.